Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Aug;25(1):13-24.
doi: 10.1385/CRIAI:25:1:13.

Osteonecrosis in patients with SLE

Mahmoud Abu-Shakra  1 , Dan Buskila, Yehuda Shoenfeld
Affiliations
Review

Osteonecrosis in patients with SLE

Mahmoud Abu-Shakra et al. Clin Rev Allergy Immunol. 2003 Aug.

Abstract

Osteonecrosis is a clinical entity characterized by death of bone marrow and trabecular bone as a result of disruption of blood supply to the bone (1,2). Other aspects of this condition include avascular necrosis, aseptic necrosis, and osseous ischemic necrosis of bones. Osteonecrosis is classified into two main forms; post-traumatic and nontraumatic. The post-traumatic form of osteonecrosis usually develops as a result of traumatic displacement of bone fragments, which leads to impaired blood supply and ischemia to the affected bone. Osteonecrosis of the femoral head is common following fracture of the femoral neck. A variety of systemic diseases and clinical conditions are associated with nontraumatic osteonecrosis. These include autoimmune rheumatic diseases, alcoholism, pregnancy, Gaucher's disease, thrombophilia, corticosteroid therapy, Sickle-cell anemia, pancreatitis, inflammatory bowel diseases, and use of cytotoxic drugs and others. Idiopathic forms of osteonecrosis have also been reported (2-4). Among the rheumatic diseases, osteonecrosis is strongly associated with systemic lupus erythematosus (SLE) (5). However, osteonecrosis has been diagnosed in patients with primary antiphospholipid syndrome (APS) (6), rheumatoid arthritis (7), and systemic vasculitis (8). This article reviews the causes, clinical and epidemiological features, diagnosis, and treatment options for osteonecrosis among patients with SLE.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Rheumatol. 2000 Apr;27(4):919-23 - PubMed
    1. Clin Orthop Relat Res. 1996 Mar;(324):169-78 - PubMed
    1. Br J Rheumatol. 1998 Aug;37(8):895-900 - PubMed
    1. JAMA. 1964 Oct 12;190:104-11 - PubMed
    1. Lupus. 1996 Aug;5(4):323-7 - PubMed

MeSH terms

LinkOut - more resources